ELYS GAME TECHNOLOGY CORP (ELYS)

US2907341026 - Common Stock

0.41  -0.1 (-19.21%)

After market: 0.1396 -0.27 (-65.95%)

Fundamental Rating

2

ELYS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 135 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of ELYS have multiple concerns. ELYS is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year ELYS has reported negative net income.
In the past year ELYS has reported a negative cash flow from operations.
ELYS had negative earnings in each of the past 5 years.
In the past 5 years ELYS reported 4 times negative operating cash flow.

1.2 Ratios

ELYS's Return On Assets of -78.33% is on the low side compared to the rest of the industry. ELYS is outperformed by 96.40% of its industry peers.
Looking at the Return On Equity, with a value of -296.29%, ELYS is doing worse than 71.94% of the companies in the same industry.
Industry RankSector Rank
ROA -78.33%
ROE -296.29%
ROIC N/A
ROA(3y)-49%
ROA(5y)-39.27%
ROE(3y)-129.85%
ROE(5y)-106.28%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ELYS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

ELYS does not have a ROIC to compare to the WACC, probably because it is not profitable.
ELYS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ELYS has been increased compared to 5 years ago.
ELYS has a worse debt/assets ratio than last year.

2.2 Solvency

ELYS has an Altman-Z score of -4.19. This is a bad value and indicates that ELYS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -4.19, ELYS is not doing good in the industry: 94.24% of the companies in the same industry are doing better.
ELYS has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
ELYS's Debt to Equity ratio of 0.38 is fine compared to the rest of the industry. ELYS outperforms 70.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z -4.19
ROIC/WACCN/A
WACC8.28%

2.3 Liquidity

A Current Ratio of 0.52 indicates that ELYS may have some problems paying its short term obligations.
ELYS has a Current ratio of 0.52. This is in the lower half of the industry: ELYS underperforms 76.98% of its industry peers.
ELYS has a Quick Ratio of 0.52. This is a bad value and indicates that ELYS is not financially healthy enough and could expect problems in meeting its short term obligations.
ELYS has a Quick ratio of 0.52. This is in the lower half of the industry: ELYS underperforms 72.66% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.94% over the past year.
The Revenue has been growing slightly by 3.74% in the past year.
The Revenue has been growing by 13.29% on average over the past years. This is quite good.
EPS 1Y (TTM)21.94%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q34.38%
Revenue 1Y (TTM)3.74%
Revenue growth 3Y6.25%
Revenue growth 5Y13.29%
Revenue growth Q2Q9.56%

3.2 Future

The Earnings Per Share is expected to grow by 36.71% on average over the next years. This is a very strong growth
Based on estimates for the next years, ELYS will show a quite strong growth in Revenue. The Revenue will grow by 18.32% on average per year.
EPS Next Y52.64%
EPS Next 2Y36.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.52%
Revenue Next 2Y18.32%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

ELYS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ELYS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ELYS's earnings are expected to grow with 36.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.71%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ELYS!.
Industry RankSector Rank
Dividend Yield N/A

ELYS GAME TECHNOLOGY CORP

NASDAQ:ELYS (10/16/2023, 7:24:30 PM)

After market: 0.1396 -0.27 (-65.95%)

0.41

-0.1 (-19.21%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap15.91M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -78.33%
ROE -296.29%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.94
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)21.94%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y52.64%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.74%
Revenue growth 3Y6.25%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y